uniQure to Present at the Oppenheimer 25th Healthcare Conference - NYC
December 05, 2014 05:09 ET
|
uniQure
AMSTERDAM, The Netherlands, Dec. 5, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present at the Oppenheimer 25th...
uniQure Announces Results for the Third Quarter of 2014
December 01, 2014 07:33 ET
|
uniQure
Amsterdam, The Netherlands, Dec. 1, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced results for the third quarter of 2014.
Corporate Highlights...
uniQure to Host Investor Day in New York City
November 21, 2014 09:33 ET
|
uniQure
Amsterdam, The Netherlands, Nov. 21, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that it will be hosting an Investor Day and simultaneous...
uniQure to Present at Jefferies Global Healthcare Conference - London
November 10, 2014 05:03 ET
|
uniQure
AMSTERDAM, The Netherlands, Nov. 10, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that Jörn Aldag, CEO, will present a corporate overview...
AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data from Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate
October 27, 2014 06:45 ET
|
uniQure
--Top-line Results Confirming Safety, Liver Transfection Presented at ESGCT Conference--
THE HAGUE, the Netherlands, Oct. 27, 2014 (GLOBE NEWSWIRE) -- The AIPGENE Consortium, a pan-European...
uniQure to Present at the Leerink Partners Rare Disease Roundtable Conference
September 25, 2014 09:08 ET
|
uniQure
Amsterdam, The Netherlands, Sept. 25, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present at the Leerink Partners Rare...
uniQure Announces Results for the Second Quarter and First Half of 2014 and Provides Update on Gene Therapy Programs
September 02, 2014 05:41 ET
|
uniQure
AMSTERDAM, the Netherlands, Sept. 2, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced results for the second quarter of 2014 and an update on...
uniQure Acquires Cardiology Gene Therapy Company InoCard
August 11, 2014 16:35 ET
|
uniQure
AMSTERDAM, Netherlands, Aug. 11, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an innovative, early-stage...
Chiesi and uniQure Provide Update on Glybera(r) Launch
August 04, 2014 07:11 ET
|
uniQure
AMSTERDAM, the Netherlands, and PARMA, Italy, Aug. 4, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, and Chiesi Farmaceutici S.p.A. ("Chiesi"), a leading...
uniQure Secures Additional $10M Venture Loan from Hercules Capital
July 01, 2014 05:16 ET
|
uniQure
AMSTERDAM, the Netherlands, July 1, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced the closing of an additional $10 million venture debt loan...